Doctropicale
ActiveSummary
Doctropicale has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €164k and a net result of €69k. Equity is growing by ~37.7% per year across the filed fiscal years. Its solvency ranks better than 82% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
96
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100▲+14
Solvency100=
Growth78▲+26
Track record94
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €15k at 30 days acceptable
Liquidity ample (current ratio 8.96 against 6.16 in 2024; short-term debt: 10.6% and cash: 32.8% of total assets), and 10.6% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
89.4%
Return on assets
37.3%
Age of the figures
9 mo
neutral · A punctual record breaks
This company filed 3 consecutive financial years on time. The year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 25-08-2026, 25 days late. Weigh it accordingly: a break into the 1-to-90-day band measures 1.41% abnormal legal state, below the 1.66% market average. It is a change in behaviour, not evidence of elevated risk.
NBB · 4 filingsDeviation from the deadline
2025
25 d late
2024
36 d early
2023
35 d early
2022
94 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€164k▲ 66.0%
2024 · €99k
2022: €63k
2023: €86k
2024: €99k
2022 → 2025
Total assets
€184k▲ 51.9%
2024 · €121k
2022: €107k
2023: €113k
2024: €121k
2022 → 2025
Net result
€69k▲ 320%
2024 · €16k
2022: €61k
2023: €27k
2024: €16k
2022 → 2025
Working capital
€156k▲ 78.1%
2024 · €87k
2022: €49k
2023: €73k
2024: €87k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2022202320242025Trend
Equity€63k-€86k▲ 37.5%€99k▲ 15.1%€164k▲ 66.0%
Operating result€77k-€34k▼ 56.0%€21k▼ 38.2%€86k▲ 311%
Net result€61k-€27k▼ 56.1%€16k▼ 38.7%€69k▲ 320%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 311% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €184k
Fixed assets
€9k ▼ 48.0%
Current assets
€175k ▲ 67.9%
Equity and liabilities €184k
Equity
€164k ▲ 66.0%
Debt
€20k ▼ 11.2%
Debt's share of the balance-sheet total falls from 18.2% to 10.6%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€94k▲
2024 · €29k
Cash flow
€77k▲
2024 · €24k
Current ratio
8.96▲
2024 · 6.16
Debt to equity
0.12▼
2024 · 0.22
ROE
41.8%▲
2024 · 16.5%
ROA
37.3%▲
2024 · 13.5%
Interest coverage
620.05▲
2024 · 139.55
Debt ≤ 1 year
€20k▲
2024 · €17k
Debt > 1 year
€0▼
2024 · €5k
Income taxes
€18k▲
2024 · €4k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 44 lines
Balance sheet
Code20242025
Assets
Total assets20/58€121k€184k▲
Fixed assets21/28€17k€9k▼
Tangible fixed assets22/27€16k€8k▼
Plant, machinery and equipment23€3k€2k▼
Furniture and vehicles24€13k€6k▼
Financial fixed assets28€900€900=
Current assets29/58€104k€175k▲
Current investments50/53€70k€100k▲
Cash at bank and in hand54/58€23k€60k▲
Deferred charges and accrued income490/1€11k€15k▲
Equity and liabilities
Total equity and liabilities10/49€121k€184k▲
Equity10/15€99k€164k▲
Contributions10/11€5k€5k=
Reserves13€90k€159k▲
Distributable reserves133€90k€159k▲
Profit (loss) carried forward14€4k€499▼
Amounts payable17/49€22k€20k▼
Amounts payable after more than one year17€5k€0▼
Financial debts170/4€5k€0▼
Amounts payable within one year42/48€17k€20k▲
Current portion of amounts payable after more than one year42€6k€5k▼
Trade debts44€2k€807▼
Suppliers440/4€2k€807▼
Taxes, remuneration and social security45€4k€12k▲
Taxes450/3€4k€12k▲
Other amounts payable47/48€5k€2k▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€8k€8k=
Other operating charges640/8€387€400▲
Gross operating margin9900€29k€94k▲
Operating profit (loss)9901€21k€86k▲
Financial income75/76B€5€1k▲
Recurring financial income75€5€1k▲
Financial charges65/66B€207€151▼
Recurring financial charges65€207€151▼
Profit (loss) for the period before taxes9903€21k€87k▲
Income taxes67/77€4k€18k▲
Profit (loss) for the period9904€16k€69k▲
Profit (loss) for the period to be appropriated9905€16k€69k▲
Appropriation of the result
Profit (loss) to be appropriated9906€17k€73k▲
Profit (loss) brought forward from the previous period14P€1k€4k▲
Transfer to equity691/2€10k€69k▲
To other reserves6921€10k€69k▲
Profit to be distributed694/7€3k€3k=
Return on contributions (dividend)694€3k€3k=
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
25-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 25 days late
2025
31-12
Financial
Highest result since 2022net €69k ▲320%
Operating result €86k, net result €69k, both a record.
31-12
Financial
Equity above €150kEq €164k ▲66%
4 profitable years in a row build equity to €164k.
25-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Weakest financial yearnet €16k ▼38.7%
Net result drops to €16k, the lowest in the series; recovery starts the following year.
26-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
28-04
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Zemst · 1 establishment unit since 2021
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Pastorijstraat 371982 ZemstGround area
357 m²
Building footprint
110 m²
Volume, LiDAR
591 m³
Parcel 23092C0014/00A002, Flanders · tallest building 10.6 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Doctropicale
since 20212.323.214.930
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23092C0014/00A002 | Flanders | 357 m² | 1 · 110 m² | 10.6 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
CLIDERM
BE 0644.732.670
Anderlecht · Eq €164,438
Dr. EVH, oogarts
BE 1001.121.360
Leuven · Eq €164,560
Dokter Schrooten Leen
BE 0819.210.134
Beringen · Eq €164,433
LABNEST
BE 0788.689.380
Kortrijk · Eq €164,428
Endoverdi
BE 0791.788.630
Schaarbeek · Eq €164,335
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 6,784 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded15-10-2021
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.